Crow Y, Lebon P, Casanova J, Gresser I
J Clin Immunol. 2018; 38(6):694-698.
PMID: 30187308
DOI: 10.1007/s10875-018-0543-6.
Wagner R
Bacteriol Rev. 1963; 27:72-86.
PMID: 13998272
PMC: 441170.
DOI: 10.1128/br.27.1.72-86.1963.
SPICKARD A, Evans H, Knight V, Johnson K
J Clin Invest. 1963; 42:840-52.
PMID: 13990087
PMC: 289354.
DOI: 10.1172/JCI104776.
Sellers R
Proc R Soc Med. 1962; 55:729-32.
PMID: 13987803
PMC: 1896846.
Stuart-Harris C
Br Med J. 1962; 2(5309):869-78.
PMID: 13917941
PMC: 1926106.
DOI: 10.1136/bmj.2.5309.869.
Pathogenesis of influenza.
DAVENPORT F
Bacteriol Rev. 1961; 25:294-300.
PMID: 13883725
PMC: 441107.
DOI: 10.1128/br.25.3.294-300.1961.
Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection.
Chu C, Sheen I, Yeh C, Hsieh S, Tsai S, Liaw Y
Dig Dis Sci. 1995; 40(10):2107-12.
PMID: 7587774
DOI: 10.1007/BF02208991.
Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus.
Haller O, Arnheiter H, GRESSER I, Lindenmann J
J Exp Med. 1981; 154(1):199-203.
PMID: 6166723
PMC: 2186399.
DOI: 10.1084/jem.154.1.199.
Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.
Yoshida R, Imanishi J, Oku T, Kishida T, HAYAISHI O
Proc Natl Acad Sci U S A. 1981; 78(1):129-32.
PMID: 6165986
PMC: 319004.
DOI: 10.1073/pnas.78.1.129.
Emulsifiers that enhance susceptibility to virus infection: increased virus penetration and reduced interferon response.
Lee S, Laltoo M, Crocker J, ROZEE K
Appl Environ Microbiol. 1980; 40(4):787-93.
PMID: 6158915
PMC: 291661.
DOI: 10.1128/aem.40.4.787-793.1980.
Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus.
SOKAWA Y, Ando T, Ishihara Y
Infect Immun. 1980; 28(3):719-23.
PMID: 6156905
PMC: 551010.
DOI: 10.1128/iai.28.3.719-723.1980.
Production of interferon in mice: effect of altered gaseous environments.
Huang K, GORDON F
Appl Microbiol. 1968; 16(10):1551-6.
PMID: 5684205
PMC: 547702.
DOI: 10.1128/am.16.10.1551-1556.1968.
Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.
Singer S, Noguchi P, KIRSCHSTEIN R
Infect Immun. 1972; 5(6):957-60.
PMID: 4635505
PMC: 422471.
DOI: 10.1128/iai.5.6.957-960.1972.
The plaque-antiserum method: an assay of virus infectivity and an experimental model of virus infection.
DE Flora S
Appl Microbiol. 1974; 27(5):901-5.
PMID: 4364462
PMC: 380174.
DOI: 10.1128/am.27.5.901-905.1974.
Markers differentiating type 3 parainfluenza virus grown at 25 and 37 C.
Frickey P
Appl Microbiol. 1969; 17(4):589-95.
PMID: 4306261
PMC: 377748.
DOI: 10.1128/am.17.4.589-595.1969.
Production of interferon by alveolar macrophages.
Acton J, Myrvik Q
J Bacteriol. 1966; 91(6):2300-4.
PMID: 4287582
PMC: 316210.
DOI: 10.1128/jb.91.6.2300-2304.1966.
Genetically determined, interferon-dependent resistance to influenza virus in mice.
Haller O, Arnheiter H, GRESSER I, Lindenmann J
J Exp Med. 1979; 149(3):601-12.
PMID: 429960
PMC: 2184824.
DOI: 10.1084/jem.149.3.601.
Matrix protein from influenza A virus and its role in cross-protection in mice.
Webster R, Hinshaw V
Infect Immun. 1977; 17(3):561-6.
PMID: 409677
PMC: 421163.
DOI: 10.1128/iai.17.3.561-566.1977.
Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.
Yoshida R, Urade Y, Tokuda M, HAYAISHI O
Proc Natl Acad Sci U S A. 1979; 76(8):4084-6.
PMID: 291064
PMC: 383982.
DOI: 10.1073/pnas.76.8.4084.
Antibody responses and interferon titers in the respiratory tracts of mice after aerosolized exposure to influenza virus.
Zee Y, OSEBOLD J, Dotson W
Infect Immun. 1979; 25(1):202-7.
PMID: 225272
PMC: 414438.
DOI: 10.1128/iai.25.1.202-207.1979.
